4DX:ASX
4DMedical Ltd
AU$4.71
arrow_downward
-5.23%(-0.26) 1 天
4月28日, GMT+10 16:11:03 · AUD
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 4DX 生成关键数据洞见…
开盘价
AU$4.99
最高价
AU$4.99
最低价
AU$4.68
市值
二七.七六亿
平均成交量
八八三.七四万
成交量
四七三.二八万
52 周最高价
AU$7.55
52 周最低价
AU$0.23
每股收益
-AU$0.34
流通股数
五.九一亿
员工人数
一二四
新闻报道
来自全网
Benzinga
·
12分钟前
Tom Lee Predicts S&P 500 Above 7,700 Is 'Very Probable' As Market Clears Early-Year Risks
Simply Wall Street
·
55分钟前
Will InterDigital’s (IDCC) SMPTE-Based HDR Streaming Workflow Shift Its Core Licensing-Led Narrative?
Investor's Business Daily
·
5小时前
Dow Jones Futures: Nasdaq, S&P 500 Set More Record Highs; Micron, Nvidia, Sandisk, Alphabet Are Big Winners
资料
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
4DMedical Ltd简介